Dimensional Fund Advisors
NVNO

Dimensional Fund Advisors’s enVVeno Medical NVNO Stock Holding History

Dimensional Fund Advisors’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-461
Closed -$64.3K – 3322
2025
Q2 		$64.3K Hold
461
– – ﹤0.01% 3219
2025
Q1 		$42.4K Sell
461
-3
-0.6% -$334 ﹤0.01% 3267
2024
Q4 		$49K Sell
464
-484
-51% -$54.1K ﹤0.01% 3294
2024
Q3 		$112K Buy
948
+479
+102% +$88K ﹤0.01% 3228
2024
Q2 		$86.2K Hold
469
– – ﹤0.01% 3266
2024
Q1 		$89.3K Sell
469
-54
-10% -$9.69K ﹤0.01% 3271
2023
Q4 		$94.1K Hold
523
– – ﹤0.01% 3285
2023
Q3 		$98.7K Hold
523
– – ﹤0.01% 3314
2023
Q2 		$56.4K Sell
523
-163
-24% -$21.2K ﹤0.01% 3396
2023
Q1 		$114K Buy
686
+72
+12% +$13.5K ﹤0.01% 3286
2022
Q4 		$110 Hold
614
– – ﹤0.01% 3313
2022
Q3 		$135K Buy
+614
New +$131K ﹤0.01% 3299
2021
Q2 		– Sell
-309
Closed -$72K – 3473
2021
Q1 		$72K Buy
+309
New +$86K ﹤0.01% 3376

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's NVNO Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of enVVeno Medical (NVNO) in Q3 2025, closing a stake of 461 shares — an estimated $64.3K sold.

Dimensional Fund Advisors first reported a position in NVNO in Q1 2021 and held it in 13 quarters. The position peaked at $135K in Q3 2022. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining enVVeno Medical position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 461 enVVeno Medical shares in Q3 2025, an estimated $64.3K.
  • Dimensional Fund Advisors first reported a position in enVVeno Medical in Q1 2021 and held it in 13 quarters.
  • Dimensional Fund Advisors's enVVeno Medical position peaked at $135K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.